I-Reconstruction Psychotherapy for Anxiety Reduction
This study aims to reduce anxiety levels in individuals through I-Reconstruction Psychotherapy, measuring changes in anxiety scores using the Beck Anxiety Inventory and Hospital Anxiety and Depression Scale, from the start of the therapy to 12 months later.
Experimental: Active "I-Reconstruction" Therapy
+ Standard Care (Treatment as Usual)
Anxiety Disorders+2
+ Behavior
+ Mental Disorders
Treatment Study
Summary
Study start date: March 2, 2026
Actual date on which the first participant was enrolled.Anxiety disorders are common mental health conditions that affect millions, impacting their life quality and social functioning. While Cognitive Behavioral Therapy (CBT) and medication are known to help, many patients still struggle with full recovery, highlighting the need for new therapeutic approaches. This study focuses on the I-Reconstruction psychotherapy method, a promising new approach that targets the root causes of anxiety. The method centers around desire, possession, and satisfaction, viewing them as fundamental elements of personality that shape our interactions with the world. This research aims to understand how this method can reduce anxiety levels in individuals with anxiety disorders, potentially filling the current treatment gap. This study is a randomized controlled trial involving three parallel groups, two experimental and one control. The participation duration is approximately 17 months, including an initial screening and assessment phase, a course of therapy sessions, and a series of delayed measurements at 3, 6, and 12 months after the intervention. Participants will be recruited online through the official pages of the NGO 'International Association of Psychosomatics and Health Therapy'. The primary outcomes measured include changes in anxiety levels using the Beck Anxiety Inventory (BAI) and the Hospital Anxiety and Depression Scale - Anxiety (HADS-A) subscale scores from baseline to 12 months after therapy. Additionally, changes in the total score according to the 'I - Reconstruction' diagnosis of preverbal dysregulation (DPD) method will also be evaluated.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.36 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 55 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalGroup III
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
International Association of Psychosomatics and Body Therapy
Kyiv, UkraineOpen International Association of Psychosomatics and Body Therapy in Google Maps